Department of Internal Medicine, Division of Infectious Diseases, Washington University, St. Louis, Missouri, USA.
Vaccine R&D Center, University of California, Irvine, Irvine, California, USA.
Infect Immun. 2021 Apr 16;89(5). doi: 10.1128/IAI.00041-21.
Enterotoxigenic (ETEC) contributes significantly to the substantial burden of infectious diarrhea among children living in low- and middle-income countries. In the absence of a vaccine for ETEC, children succumb to acute dehydration as well as nondiarrheal sequelae related to these infections, including malnutrition. The considerable diversity of ETEC genomes has complicated canonical vaccine development approaches defined by a subset of ETEC pathovar-specific antigens known as colonization factors (CFs). To identify additional conserved immunogens unique to this pathovar, we employed an "open-aperture" approach to capture all potential conserved ETEC surface antigens, in which we mined the genomic sequences of 89 ETEC isolates, bioinformatically selected potential surface-exposed pathovar-specific antigens conserved in more than 40% of the genomes ( = 118), and assembled the representative proteins onto microarrays, complemented with known or putative colonization factor subunit molecules ( = 52) and toxin subunits. These arrays were then used to interrogate samples from individuals with acute symptomatic ETEC infections. Surprisingly, in this approach, we found that immune responses were largely constrained to a small number of antigens, including individual colonization factor antigens and EtpA, an extracellular adhesin. In a Bangladeshi cohort of naturally infected children <2 years of age, both EtpA and a second antigen, EatA, elicited significant serologic responses that were associated with protection from symptomatic illness. In addition, children infected with ETEC isolates bearing either or genes were significantly more likely to develop symptomatic disease. These studies support a role for antigens not presently targeted by vaccines (noncanonical) in virulence and the development of adaptive immune responses during ETEC infections. These findings may inform vaccine design efforts to complement existing approaches.
肠毒素性(ETEC)大肠杆菌对生活在中低收入国家的儿童中大量传染性腹泻负担有重大影响。由于没有针对 ETEC 的疫苗,儿童会死于急性脱水以及与这些感染相关的非腹泻后遗症,包括营养不良。ETEC 基因组的巨大多样性使得基于定植因子(CF)等 ETEC 变体特异性抗原子集的规范疫苗开发方法变得复杂。为了确定针对这种变体的其他保守免疫原,我们采用了一种“开放孔径”方法来捕获所有潜在的保守 ETEC 表面抗原,其中我们挖掘了 89 个 ETEC 分离株的基因组序列,生物信息学选择了超过 40%的基因组中保守的潜在表面暴露变体特异性抗原( = 118),并将代表性蛋白质组装到微阵列上,补充已知或假定的定植因子亚单位分子( = 52)和毒素亚单位。然后,这些阵列用于检测急性症状性 ETEC 感染个体的样本。令人惊讶的是,在这种方法中,我们发现免疫反应主要局限于少数抗原,包括单个定植因子抗原和外膜黏附素 EtpA。在一个年龄<2 岁的自然感染儿童的孟加拉队列中,EtpA 和第二种抗原 EatA 都引起了显著的血清学反应,与对有症状疾病的保护有关。此外,携带 或 基因的 ETEC 分离株感染的儿童更有可能发生有症状的疾病。这些研究支持了目前疫苗(非规范)未靶向的抗原在 ETEC 感染期间的毒力和适应性免疫反应发展中的作用。这些发现可能为补充现有方法的疫苗设计工作提供信息。